Immunotherapy, Blog, Cancer
Gregory Beatty
Biomarkers for CD40 immunotherapy

The neutrophil to lymphocyte ratio is a prognostic biomarker of CD40 immunotherapy.

Comment

The Beatty Laboratory is part of the Perelman School of Medicine at the University of Pennsylvania.